Asset Details
Do you wish to reserve the book?
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Do you wish to request the book?
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
2010
Overview
Human African trypanosomiasis, endemic to sub-Saharan Africa, is invariably fatal if untreated. Its causative agent is the protozoan parasite Trypanosoma brucei. Eflornithine is used as a first line treatment for human African trypanosomiasis, but there is a risk that resistance could thwart its use, even when used in combination therapy with nifurtimox. Eflornithine resistant trypanosomes were selected in vitro and subjected to biochemical and genetic analysis. The resistance phenotype was verified in vivo. Here we report the molecular basis of resistance. While the drug's target, ornithine decarboxylase, was unaltered in resistant cells and changes to levels of metabolites in the targeted polyamine pathway were not apparent, the accumulation of eflornithine was shown to be diminished in resistant lines. An amino acid transporter gene, TbAAT6 (Tb927.8.5450), was found to be deleted in two lines independently selected for resistance. Ablating expression of this gene in wildtype cells using RNA interference led to acquisition of resistance while expression of an ectopic copy of the gene introduced into the resistant deletion lines restored sensitivity, confirming the role of TbAAT6 in eflornithine action. Eflornithine resistance is easy to select through loss of a putative amino acid transporter, TbAAT6. The loss of this transporter will be easily identified in the field using a simple PCR test, enabling more appropriate chemotherapy to be administered.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Amino Acid Transport Systems - antagonists & inhibitors
/ Amino Acid Transport Systems - genetics
/ Amino Acid Transport Systems - metabolism
/ Animals
/ Eflornithine - therapeutic use
/ Humans
/ Infectious Diseases/Neglected Tropical Diseases
/ Mice
/ Ornithine Decarboxylase Inhibitors
/ Pharmacology/Drug Resistance
/ Principal components analysis
/ RNA, Small Interfering - genetics
/ Trypanocidal Agents - therapeutic use
/ Trypanosoma brucei brucei - drug effects
/ Trypanosoma brucei brucei - metabolism
/ Trypanosoma brucei brucei - pathogenicity
